Core Viewpoint - Guanshi Technology (605588.SH) plans to raise a maximum of 700 million yuan through a private placement of shares, with proceeds allocated for a photomask manufacturing project and to supplement working capital [1][2]. Financial Summary - The total estimated investment for the photomask manufacturing project is 1.931 billion yuan, with 530 million yuan expected to be funded from the raised capital. Additionally, 170 million yuan will be allocated to supplement working capital, bringing the total to 2.101 billion yuan [2]. - The company reported revenues of 1.359 billion yuan for 2024, a 51.95% increase compared to the previous year, while the net profit attributable to shareholders was a loss of 15.5 million yuan, a decline of 129.6% [4][5]. - For the first half of 2025, the company recorded revenues of 691.5 million yuan, a 5.3% increase year-on-year, but the net profit attributable to shareholders was a loss of 12.2 million yuan, representing a 159.98% decline [5]. Shareholding Structure - As of the announcement date, Zhang Jianwei holds approximately 57.35% of the company's shares and indirectly controls an additional 3.06% through a partnership, totaling 60.41% of voting rights. Post-issuance, his control will decrease to 46.47%, but he will remain the controlling shareholder [2][3]. Approval Process - The proposed share issuance has been approved by the company's board and is pending approval from the shareholders' meeting, the Shanghai Stock Exchange, and registration with the China Securities Regulatory Commission [3]. Historical Context - Guanshi Technology was listed on the Shanghai Stock Exchange on August 12, 2021, raising 501 million yuan, which was fully allocated to functional structural components, ultra-high-definition LCD panels, and a research and development center [3].

Summary of Key Points Core Viewpoint The report provides a detailed account of Nanjing Guanshi Technology Co., Ltd.'s fundraising activities, including the amount raised, its usage, and management practices, ensuring compliance with regulatory requirements and protecting investor interests. Group 1: Fundraising Overview - The company raised a total of RMB 501,100,500 through the issuance of 18,275,000 shares at RMB 27.42 per share, with net proceeds amounting to RMB 455,867,927.74 after deducting issuance costs [1][2][3] - As of June 30, 2025, the company has utilized RMB 380,779,938.44 of the raised funds, leaving a remaining balance of RMB 98,261,870.03 [1][2][3] - The total amount used in the first half of 2025 was RMB 118,935,655.08, with previous years accounting for RMB 261,844,283.36 [1][2][3] Group 2: Fund Management Practices - The company has established a fundraising management system in compliance with relevant laws and regulations, ensuring funds are stored in dedicated bank accounts [1][2][3] - A tripartite supervision agreement was signed with banks and the sponsor to regulate the use and storage of the funds, which has been strictly adhered to [1][2][3] - As of June 30, 2025, the company has canceled the fundraising accounts as per the regulatory requirements [1][2][3] Group 3: Fund Usage and Project Updates - The company has invested RMB 11,893.56 million in fundraising projects during the reporting period, with a cumulative investment of RMB 38,077.99 million [5][6][7] - A significant portion of the funds has been redirected to the "Photomask Manufacturing Project," with 56.27% of the total funds being reallocated due to market demand fluctuations [5][6][7] - The company has not encountered any issues with the use of funds, and all activities have been reported transparently [5][6][7]